| Primary |
| Drug Use For Unknown Indication |
32.4% |
| Product Used For Unknown Indication |
17.4% |
| Atypical Mycobacterial Infection |
5.5% |
| Hypertension |
4.8% |
| Pneumonia |
4.6% |
| Helicobacter Infection |
4.3% |
| Bronchitis |
4.2% |
| Pyrexia |
2.9% |
| Gastritis |
2.3% |
| Nasopharyngitis |
2.3% |
| Prophylaxis |
2.3% |
| Diabetes Mellitus |
2.3% |
| Atrial Fibrillation |
2.2% |
| Lower Respiratory Tract Infection |
2.0% |
| Pneumonia Legionella |
2.0% |
| Mycobacterial Infection |
1.8% |
| Mycobacterium Avium Complex Infection |
1.8% |
| Osteoporosis |
1.8% |
| Productive Cough |
1.6% |
| Constipation |
1.5% |
|
| Rhabdomyolysis |
9.8% |
| Pyrexia |
8.8% |
| Respiratory Failure |
8.8% |
| Eosinophilic Pneumonia |
6.9% |
| Vomiting |
6.9% |
| Weight Decreased |
6.9% |
| Interstitial Lung Disease |
4.9% |
| Oropharyngeal Blistering |
3.9% |
| Rash |
3.9% |
| Renal Failure Acute |
3.9% |
| Renal Impairment |
3.9% |
| Stevens-johnson Syndrome |
3.9% |
| Stomatitis |
3.9% |
| Swollen Tongue |
3.9% |
| Transaminases Increased |
3.9% |
| Urticaria |
3.9% |
| Anosmia |
2.9% |
| Electroencephalogram Abnormal |
2.9% |
| Hepatic Function Abnormal |
2.9% |
| Hypoglycaemia |
2.9% |
|
| Secondary |
| Drug Use For Unknown Indication |
15.6% |
| Pyrexia |
7.9% |
| Product Used For Unknown Indication |
7.0% |
| Helicobacter Infection |
6.6% |
| Hypertension |
6.2% |
| Mycobacterium Avium Complex Infection |
5.2% |
| Rheumatoid Arthritis |
4.8% |
| Upper Respiratory Tract Inflammation |
4.6% |
| Atrial Fibrillation |
4.4% |
| Pneumonia |
4.3% |
| Productive Cough |
4.3% |
| Emphysema |
4.1% |
| Hiv Infection |
4.1% |
| Osteoporosis Prophylaxis |
3.3% |
| Prophylaxis |
3.3% |
| Asthma |
3.0% |
| Bronchitis |
2.9% |
| Depression |
2.9% |
| Mycobacterial Infection |
2.8% |
| Osteoporosis |
2.6% |
|
| White Blood Cell Count Increased |
8.1% |
| Platelet Count Decreased |
7.1% |
| Eosinophilic Pneumonia |
6.1% |
| Staphylococcal Sepsis |
6.1% |
| Tonic Convulsion |
6.1% |
| Vomiting |
6.1% |
| White Blood Cell Count Decreased |
6.1% |
| Drug Ineffective |
5.1% |
| Hypoglycaemia |
5.1% |
| Renal Disorder |
5.1% |
| Respiratory Failure |
5.1% |
| Rhabdomyolysis |
5.1% |
| Stevens-johnson Syndrome |
5.1% |
| Torsade De Pointes |
5.1% |
| Pyrexia |
4.0% |
| Interstitial Lung Disease |
3.0% |
| Liver Disorder |
3.0% |
| Neuroleptic Malignant Syndrome |
3.0% |
| Oral Discomfort |
3.0% |
| Rectal Cancer |
3.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
29.8% |
| Prophylaxis |
12.6% |
| Rheumatoid Arthritis |
11.9% |
| Hypertension |
4.9% |
| Pneumonia |
4.2% |
| Bronchitis |
3.9% |
| Influenza |
3.8% |
| Mycobacterium Avium Complex Infection |
3.1% |
| Asthma |
3.0% |
| Plasma Cell Myeloma |
2.6% |
| Constipation |
2.6% |
| Product Used For Unknown Indication |
2.6% |
| Insomnia |
2.2% |
| Osteoporosis |
2.2% |
| Angina Pectoris |
1.9% |
| Bronchitis Chronic |
1.8% |
| Immunosuppressant Drug Therapy |
1.8% |
| Chronic Myeloid Leukaemia |
1.7% |
| Hiv Infection |
1.7% |
| Diabetes Mellitus |
1.6% |
|
| White Blood Cell Count Decreased |
16.3% |
| Interstitial Lung Disease |
6.9% |
| Pneumonia |
6.9% |
| Hepatic Function Abnormal |
6.4% |
| Loss Of Consciousness |
5.4% |
| Vomiting |
5.4% |
| Tachycardia |
5.0% |
| Liver Disorder |
4.5% |
| Pneumonia Aspiration |
4.5% |
| Respiratory Failure |
4.5% |
| Restlessness |
4.5% |
| Vision Blurred |
4.5% |
| Pyrexia |
4.0% |
| Sepsis |
3.5% |
| Abnormal Behaviour |
3.0% |
| Allergic Granulomatous Angiitis |
3.0% |
| Bipolar Disorder |
3.0% |
| Cardiogenic Shock |
3.0% |
| Platelet Count Decreased |
3.0% |
| Thrombocytopenia |
3.0% |
|
| Interacting |
| Osteoporosis |
19.2% |
| Hypertension |
10.4% |
| Nasopharyngitis |
10.4% |
| Rheumatoid Arthritis |
9.6% |
| Mycobacterial Infection |
6.4% |
| Abdominal Mass |
4.8% |
| Bronchopulmonary Aspergillosis |
4.8% |
| Gastritis |
4.8% |
| Mycobacterium Avium Complex Infection |
4.8% |
| Periodontitis |
3.2% |
| Pneumonia |
3.2% |
| Product Used For Unknown Indication |
3.2% |
| Atrial Fibrillation |
2.4% |
| Atypical Mycobacterial Infection |
2.4% |
| Upper Respiratory Tract Inflammation |
2.4% |
| Arrhythmia |
1.6% |
| Diabetes Mellitus |
1.6% |
| Glaucoma |
1.6% |
| Myocardial Ischaemia |
1.6% |
| Productive Cough |
1.6% |
|
| Vomiting |
37.5% |
| Uveitis |
18.8% |
| Eosinophilic Pneumonia |
12.5% |
| Bradycardia |
6.3% |
| Nocturia |
6.3% |
| Periodontitis |
6.3% |
| Shock |
6.3% |
| Urinary Retention |
6.3% |
|
